Cargando…
Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model
BACKGROUND: Alexander disease (AxD) is an astrogliopathy that predominantly affects the white matter of the central nervous system (CNS), and is caused by a mutation in the gene encoding the glial fibrillary acidic protein (GFAP), an intermediate filament primarily expressed in astrocytes and ependy...
Autores principales: | Lee, So-Hyun, Nam, Tai-Seung, Kim, Kun-Hee, Kim, Jin Hee, Yoon, Woong, Heo, Suk-Hee, Kim, Min Jung, Shin, Boo Ahn, Perng, Ming-Der, Choy, Hyon E., Jo, Jihoon, Kim, Myeong-Kyu, Choi, Seok-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590178/ https://www.ncbi.nlm.nih.gov/pubmed/28882119 http://dx.doi.org/10.1186/s12883-017-0938-7 |
Ejemplares similares
-
A Novel GFAP Mutation in Late-Onset Alexander Disease Showing Diffusion Restriction
por: Nam, Tai-Seung, et al.
Publicado: (2017) -
Effects of Alexander disease–associated mutations on the assembly and organization of GFAP intermediate filaments
por: Yang, Ai-Wen, et al.
Publicado: (2022) -
CSF and Blood Levels of GFAP in Alexander Disease
por: Jany, Paige L., et al.
Publicado: (2015) -
Refining the concept of GFAP toxicity in Alexander disease
por: Messing, Albee
Publicado: (2019) -
Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity
por: Battaglia, Rachel A, et al.
Publicado: (2019)